Using Reverse Genetic Techniques to Develop Next-generation Live Attenuated Vaccines for Porcine Epidemic Diarrhea

Elena Bosis^*
*Correspondence: Elena Bosis, Department of Animal Breeding & Husbandry, Agricultural University of Athens, Athens, Greece, Email:

Introduction

Porcine Epidemic Diarrhea Virus (PEDV) is a highly contagious virus that affects swine, causing severe enteric disease characterized by diarrhea, vomiting, and high mortality rates, particularly in neonatal piglets. Since its first emergence, PEDV has had a significant economic impact on the swine industry worldwide. The control and prevention of PEDV have been major challenges, primarily due to the lack of effective vaccines. Traditional vaccine development strategies have had limited success, prompting the exploration of more advanced techniques. Among these, reverse genetic techniques have emerged as a promising approach for developing next-generation Live Attenuated Vaccines (LAVs) for PEDV [1].

Reverse genetics refers to the manipulation of viral genomes to understand the function of specific genes and to engineer viruses with desired properties. Unlike conventional methods that rely on natural selection and random mutagenesis, reverse genetics allows for precise and targeted modifications. This precision is particularly advantageous in vaccine development, as it enables the creation of attenuated viruses that can elicit strong immune responses without causing disease. For PEDV, reverse genetics provides a powerful tool to design vaccines that are both safe and effective. The development of reverse genetic systems for PEDV has been a significant milestone. These systems involve the synthesis of full-length cDNA clones of the viral genome, which can be manipulated in vitro and subsequently used to generate infectious virus particles [2].

Description

One of the key advantages of using reverse genetics in vaccine development is the ability to design rationally attenuated viruses. Traditional LAVs are typically derived through serial passage of the virus in cell culture or in animals, leading to the accumulation of mutations that reduce virulence. However, this process is often unpredictable and time-consuming. In contrast, reverse genetics allows for the deliberate introduction of mutations that are known to attenuate the virus. For example, mutations that affect the viral polymerase, spike protein, or other non-structural proteins can be engineered to reduce viral replication and virulence. These rationally designed attenuations can produce more consistent and safer vaccine candidates. The spike (S) protein of PEDV, which mediates viral entry into host cells, is a primary target for genetic modifications. The S protein is highly immunogenic and plays a crucial role in inducing neutralizing antibodies [3].

By manipulating the S gene, researchers can create mutant viruses that exhibit reduced pathogenicity but still provoke a robust immune response. For instance, deletion of certain regions in the S protein that are involved in receptor binding or fusion can attenuate the virus without compromising its ability to induce immunity. These modified viruses can serve as effective LAVs, providing protection against PEDV infection. Another approach involves the alteration of viral non-structural proteins (nsps), which are essential for viral replication and immune evasion. By targeting these proteins, researchers can disrupt critical viral functions and enhance the host immune response. For example, mutations in nsp3, nsp5, or nsp16 can impair viral replication and immune modulation, leading to attenuated viruses that are less capable of causing disease. Such modifications can be incorporated into vaccine strains to improve their safety and efficacy. In addition to rational attenuation, reverse genetics allows for the incorporation of marker genes or reporter constructs into the viral genome [4].

The application of reverse genetics in PEDV vaccine development is not without challenges. One of the main obstacles is the stability of the engineered viruses. Attenuating mutations introduced into the viral genome must be stable and not revert to a virulent form. Ensuring genetic stability requires careful selection of mutations and thorough evaluation of their effects on viral fitness and immune responses. Additionally, the production of reverse genetic systems and the generation of infectious virus particles require specialized facilities and expertise, which can be resource-intensive. Despite these challenges, the potential benefits of reverse genetic techniques in developing next-generation LAVs for PEDV are substantial. The ability to design targeted mutations and rationally attenuate the virus holds promise for creating vaccines that are both safe and effective. These vaccines can induce strong and lasting immunity, providing protection against PEDV outbreaks and reducing the economic burden on the swine industry [5].

Conclusion

The use of reverse genetics also opens the door to the development of multivalent vaccines. By incorporating antigens from multiple swine pathogens into a single viral vector, researchers can create vaccines that protect against several diseases simultaneously. This approach can enhance the efficiency of vaccination programs and reduce the number of inoculations required for swine herds. Furthermore, the flexibility of reverse genetic systems allows for the rapid adaptation of vaccines to emerging PEDV strains, ensuring that vaccine formulations remain relevant and effective in the face of viral evolution.

In conclusion, reverse genetic techniques represent a powerful and innovative approach for developing next-generation live attenuated vaccines for porcine epidemic diarrhea virus. By enabling precise and targeted modifications of the viral genome, these techniques allow for the rational design of attenuated viruses that are safe, immunogenic, and genetically stable. The ability to manipulate viral genes and incorporate reporter constructs provides valuable tools for studying PEDV pathogenesis and immune responses, ultimately guiding the development of more effective vaccines. Despite the challenges associated with reverse genetics, the potential benefits for controlling and preventing PEDV are significant. As research in this field continues to advance, reverse genetics is likely to play a central role in the development of new and improved vaccines for PEDV and other swine pathogens, contributing to the overall health and productivity of the swine industry.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Pensaert, Maurice B. and Paolo Martelli. "Porcine epidemic diarrhea: A retrospect from Europe and matters of debate." Vir Res 226 (2016): 1-6.

Google Scholar, Crossref, Indexed at

2. Wang, Yue, Jia-rong Li, Ming-xia Sun and Bo Ni, et al. "Triggering unfolded protein response by 2-Deoxy-D-glucose inhibits porcine epidemic diarrhea virus propagation." Antiviral Res 106 (2014): 33-41.

Google Scholar, Crossref, Indexed at

3. Zhang, Yu, Yueyue Liu, Shifa Yang and Bin Yin, et al. "Water extract of portulaca oleracea inhibits PEDV infection-induced pyrolysis by caspase-1/GSDMD." Curr Iss Molecular Biol 45 (2023): 10211-10224.

Google Scholar, Crossref, Indexed at

4. Zhang, Hongliang, Yingguang Li, Ruimei Yang and Ling Xiao, et al. "Erastin inhibits porcine epidemic diarrhea virus replication in Vero cells." Front Cell Infect Microbiol 13 (2023): 1142173.

Google Scholar, Crossref, Indexed at

5. Salmon, Henri, Mustapha Berri, Volker Gerdts and François Meurens. "Humoral and cellular factors of maternal immunity in swine." Develop Comparative Immunol 33 (2009): 384-393.

Google Scholar, Crossref, Indexed at